About: Amadeus is one of Europe’s leading technology investors and based in London and Cambridge. Since its inception in 1997, the firm has backed over 70 companies covering computer hardware and software, mobile and fixed communications technologies, medical technologies and clean technologies. With £460m under management, it has active investments in around 40 companies at any time, across Europe and selectively in Israel. Investments include Celltick, the global market leader in mobile idle screen marketing, CSR, producing single chip bluetooth radios for short range connections and floated on the London Stock Exchange in 2004, Optos, a manufacturer of laser retinal scanners and floated on the London Stock Exchange in 2006, Solexa, the developer of next generation genetic analysis systems, merged with Illumina Inc., which is quoted on NASDAQ, and Transmode, the European market leader in metro data transport systems.
Anne Glover, co-founder and CEO
Hermann Hauser, co-founder
Richard Anton, Partner
Simon Cornwell, Partner
Andrea Traversone, Partner
News: In July 2008, GreenRoad Technologies, a world leader in driver safety technologies, announced that Amadeus Capital Partners, the European technology investor, has joined Virgin Green Fund, Benchmark Capital, and Balderton Capital in providing C round financing of $17.5 million. The funding will be used to expand the company’s R&D, sales and marketing efforts. Richard Anton, Amadeus Partner, becomes the newest member of GreenRoad’s Board of Directors.
In May 2009, GreenRoad announced that it has raised $15 million in growth funding. DAG Ventures, a venture capital investment partnership, led the round with participation from existing investors Benchmark Capital, Virgin Green Fund, Amadeus Capital and Balderton Capital. GreenRoad also announced that Nick Pianim, managing director at DAG Ventures, was appointed to the company’s board of directors.
Pat Burtis, an investment manager with Amadeus, focuses on the Cleantech sector. Prior to Amadeus, he was an independent management consultant for 7 years in the cleantech, life sciences and materials science fields. He co-led Amadeus’ investment in GreenRoad.
With £10 million under management and up to £10 million for co-investment from Amadeus III, the Amadeus and Angels Seed Fund (AASF) focuses on seed stage technology companies in the UK. AASF is jointly funded by Amadeus, the UK Department for Business Enterprise and Regulatory Reform, business angels and private investors. As a result, AASF has access to proprietary, high-quality deal flow, complemented by the discipline of a large VC fund and the expert knowledge of business angels.